359 related articles for article (PubMed ID: 18305228)
21. Impaired interaction between skeletal ryanodine receptors in malignant hyperthermia.
Liang X; Chen K; Fruen B; Hu J; Ma J; Hu X; Parness J
Integr Biol (Camb); 2009 Sep; 1(8-9):533-9. PubMed ID: 20023768
[TBL] [Abstract][Full Text] [Related]
22. RYR1 mutations causing central core disease are associated with more severe malignant hyperthermia in vitro contracture test phenotypes.
Robinson RL; Brooks C; Brown SL; Ellis FR; Halsall PJ; Quinnell RJ; Shaw MA; Hopkins PM
Hum Mutat; 2002 Aug; 20(2):88-97. PubMed ID: 12124989
[TBL] [Abstract][Full Text] [Related]
23. Abnormal membrane properties of the sarcoplasmic reticulum of pigs susceptible to malignant hyperthermia: modes of action of halothane, caffeine, dantrolene, and two other drugs.
Ohnishi ST; Waring AJ; Fang SR; Horiuchi K; Flick JL; Sadanaga KK; Ohnishi T
Arch Biochem Biophys; 1986 Jun; 247(2):294-301. PubMed ID: 2424370
[TBL] [Abstract][Full Text] [Related]
24. Dantrolene inhibition of sarcoplasmic reticulum Ca2+ release by direct and specific action at skeletal muscle ryanodine receptors.
Fruen BR; Mickelson JR; Louis CF
J Biol Chem; 1997 Oct; 272(43):26965-71. PubMed ID: 9341133
[TBL] [Abstract][Full Text] [Related]
25. Ryanodine modification of RyR1 retrogradely affects L-type Ca(2+) channel gating in skeletal muscle.
Bannister RA; Beam KG
J Muscle Res Cell Motil; 2009; 30(5-6):217-23. PubMed ID: 19802526
[TBL] [Abstract][Full Text] [Related]
26. Malignant hyperthermia, environmental heat stress, and intracellular calcium dysregulation in a mouse model expressing the p.G2435R variant of RYR1.
Lopez JR; Kaura V; Diggle CP; Hopkins PM; Allen PD
Br J Anaesth; 2018 Oct; 121(4):953-961. PubMed ID: 30236258
[TBL] [Abstract][Full Text] [Related]
27. Muscle weakness in Ryr1I4895T/WT knock-in mice as a result of reduced ryanodine receptor Ca2+ ion permeation and release from the sarcoplasmic reticulum.
Loy RE; Orynbayev M; Xu L; Andronache Z; Apostol S; Zvaritch E; MacLennan DH; Meissner G; Melzer W; Dirksen RT
J Gen Physiol; 2011 Jan; 137(1):43-57. PubMed ID: 21149547
[TBL] [Abstract][Full Text] [Related]
28. Results of contracture tests with halothane, caffeine, and ryanodine depend on different malignant hyperthermia-associated ryanodine receptor gene mutations.
Fiege M; Wappler F; Weisshorn R; Ulrich Gerbershagen M; Steinfath M; Schulte Am Esch J
Anesthesiology; 2002 Aug; 97(2):345-50. PubMed ID: 12151923
[TBL] [Abstract][Full Text] [Related]
29. 3,5-Di-t-butyl catechol is a potent human ryanodine receptor 1 activator, not suitable for the diagnosis of malignant hyperthermia susceptibility.
Lacava C; Michalek-Sauberer A; Kraft B; Sgaragli G; Sipos E; Höller C; Kress HG; Fusi F; Weigl LG
Pharmacol Res; 2012 Jul; 66(1):80-7. PubMed ID: 22480578
[TBL] [Abstract][Full Text] [Related]
30. Dantrolene sodium can increase or attenuate activity of skeletal muscle ryanodine receptor calcium release channel. Clinical implications.
Nelson TE; Lin M; Zapata-Sudo G; Sudo RT
Anesthesiology; 1996 Jun; 84(6):1368-79. PubMed ID: 8669678
[TBL] [Abstract][Full Text] [Related]
31. Mutations to Gly2370, Gly2373 or Gly2375 in malignant hyperthermia domain 2 decrease caffeine and cresol sensitivity of the rabbit skeletal-muscle Ca2+-release channel (ryanodine receptor isoform 1).
Du GG; Oyamada H; Khanna VK; MacLennan DH
Biochem J; 2001 Nov; 360(Pt 1):97-105. PubMed ID: 11695996
[TBL] [Abstract][Full Text] [Related]
32. A retrograde signal from RyR1 alters DHP receptor inactivation and limits window Ca2+ release in muscle fibers of Y522S RyR1 knock-in mice.
Andronache Z; Hamilton SL; Dirksen RT; Melzer W
Proc Natl Acad Sci U S A; 2009 Mar; 106(11):4531-6. PubMed ID: 19246389
[TBL] [Abstract][Full Text] [Related]
33. Store-operated Ca2+ entry in malignant hyperthermia-susceptible human skeletal muscle.
Duke AM; Hopkins PM; Calaghan SC; Halsall JP; Steele DS
J Biol Chem; 2010 Aug; 285(33):25645-53. PubMed ID: 20566647
[TBL] [Abstract][Full Text] [Related]
34. Characterization of recombinant rabbit cardiac and skeletal muscle Ca2+ release channels (ryanodine receptors) with a novel [3H]ryanodine binding assay.
Du GG; Imredy JP; MacLennan DH
J Biol Chem; 1998 Dec; 273(50):33259-66. PubMed ID: 9837897
[TBL] [Abstract][Full Text] [Related]
35. Sevoflurane modulation of Ca2+ regulation in skeletal muscle sarcoplasmic reticulum vesicles from young and mature rabbits.
König M; Lin M; Nelson TE; Groban L
Paediatr Anaesth; 2009 Dec; 19(12):1166-74. PubMed ID: 19863735
[TBL] [Abstract][Full Text] [Related]
36. Coupled gating of skeletal muscle ryanodine receptors is modulated by Ca2+, Mg2+, and ATP.
Porta M; Diaz-Sylvester PL; Neumann JT; Escobar AL; Fleischer S; Copello JA
Am J Physiol Cell Physiol; 2012 Sep; 303(6):C682-97. PubMed ID: 22785120
[TBL] [Abstract][Full Text] [Related]
37. A central core disease mutation in the Ca
Chirasani VR; Xu L; Addis HG; Pasek DA; Dokholyan NV; Meissner G; Yamaguchi N
Am J Physiol Cell Physiol; 2019 Aug; 317(2):C358-C365. PubMed ID: 31166712
[TBL] [Abstract][Full Text] [Related]
38. Ca2+ signaling in HEK-293 and skeletal muscle cells expressing recombinant ryanodine receptors harboring malignant hyperthermia and central core disease mutations.
Brini M; Manni S; Pierobon N; Du GG; Sharma P; MacLennan DH; Carafoli E
J Biol Chem; 2005 Apr; 280(15):15380-9. PubMed ID: 15689621
[TBL] [Abstract][Full Text] [Related]
39. Anesthetic- and heat-induced sudden death in calsequestrin-1-knockout mice.
Dainese M; Quarta M; Lyfenko AD; Paolini C; Canato M; Reggiani C; Dirksen RT; Protasi F
FASEB J; 2009 Jun; 23(6):1710-20. PubMed ID: 19237502
[TBL] [Abstract][Full Text] [Related]
40. Effects of small molecule modulators on ATP binding to skeletal ryanodine receptor.
Dias JM; Vogel PD
Protein J; 2009 Jun; 28(5):240-6. PubMed ID: 19636685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
